Merck KGaA
Merck KGaA and Pfizer enter the immunotherapy market with Bavencio
March 27, 2017Sales and Marketing Bavencio, Merck KGaA, Pfizer
Merck KGaA and Pfizer have won approval for the fourth immunotherapy treatment to enter the market, with an indication in …
Merck KGaA invests €250 million in production in China
November 4, 2016Manufacturing and Production China, Merck KGaA, Nantong, manufacturing
Merck KGaA inaugurated their Nantong pharmaceutical plant on 4 November. At the same time, Merck also announced that it plans …
EMA has validated Merck and Pfizer’s MAA for avelumab
November 1, 2016Manufacturing and Production, Sales and Marketing EMA, Merck KGaA, Pfizer, avelumab
The European Medicines Agency has validated the Marketing Authorisation Application for avelumab for the proposed indication of metastatic Merkel cell …
Merck KGaA and Pfizer team up with Debiopharm in lung cancer treatment
October 21, 2016Medical Communications Debiopharm, Merck KGaA, NSCLC, Pfizer, lung cancer
Debiopharm International, the Swiss-based global biopharmaceutical group of five companies, announced that it would be entering into an agreement with …
Merck KgaA foresees meeting 2018 objectives and plans for 2022
October 13, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 2018, 2022, Germany, Merck KGaA
Speaking at its 2016 Capital Market Day about the progress it had made towards its 2018 objectives, CEO Stefan Oschmann …
Stefan Oschmann promoted to top job at Merck KGaA
October 13, 2015Manufacturing and Production, Research and Development, Sales and Marketing Merck KGaA, Stefan Oschmann
Merck KGaA has announced the promotion of its deputy chief executive, Stefan Oschmann, to the role of chief executive, starting …
Merck KGaA’s sales climb but key drugs fall
May 19, 2015Sales and Marketing Erbitux, Merck, Merck KGaA, Q1, Rebif
Merck KGaA encountered an uneven start to 2015, with robust sales in the first quarter offset by declines in key …
Merck KGaA reveals ASCO plans
May 15, 2015Sales and Marketing ASCO, Merck, Merck KGaA, Merck Serono, avelumab
Merck KGaA is the latest company to announce its slate for this year’s ASCO conference, and like other firms it …
Merck KGaA and Pfizer alliance begins lung cancer study
April 21, 2015Research and Development, Sales and Marketing Merck KGaA, Pfizer, avelumab, keytruda, oncology, opdivo
Merck KGaA and Pfizer have enrolled and treated the first patient in a late-stage study of their anti-PD1 cancer immunotherapy …
Merck and Pfizer to co-promote cancer drug
April 9, 2015Research and Development, Sales and Marketing Cancer, Merck, Merck KGaA, NSCLC, Pfizer, Xalkori, non-small cell lung cancer, oncology
Merck KgaA and Pfizer have agreed to co-promote the latter’s lung cancer treatment Xalkori, and form a new alliance that …
Chief executive promotion at Merck KGaA
March 24, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Karl-Ludwig Kley, Merck, Merck KGaA, Merck Serono, Stefan Oschmann, chief executive
Merck KGaA is to promote its deputy chief executive Stefan Oschmann to replace Karl-Ludwig Kley in the top job next …
Pfizer signs $3 billion cancer deal
November 18, 2014Research and Development, Sales and Marketing Cancer, Merck KGaA, PD-L1, Pfizer, anti-PD-L1, opdivo
Pfizer has signed a multi-billion dollar deal to develop one of Merck KGaA’s investigational drugs, MSB0010718C, an anti-PD-L1 antibody. The …
Changes at the top for Merck KGaA
September 19, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Belén Garijo, Merck KGaA, Stefan Oschmann
German chemical and pharma giant Merck KGaA has promoted Stefan Oschmann to the position of deputy chief executive and vice …
Merck Serono rapped over hospitality
May 23, 2014Medical Communications, Sales and Marketing ABPI, Merck KGaA, Merck Serono, PMCPA
The use of ‘extravagant’ dinners and ‘excessive alcohol’ has landed Merck Serono in hot water with the PMCPA as it’s …
New head of Biosimilars for Merck KGaA
February 21, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Merck KGaA, biosimilars, simon sturge
Simon Sturge is joining Merck KGaA from Boehringer Ingelheim in order to head its Biosimilars unit. In his new role …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
